A citation-based method for searching scientific literature

Nader Sanai, Mei-Yin Polley, Michael W McDermott, Andrew T Parsa, Mitchel S Berger. J Neurosurg 2011
Times Cited: 896







List of co-cited articles
662 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.
M Lacroix, D Abi-Said, D R Fourney, Z L Gokaslan, W Shi, F DeMonte, F F Lang, I E McCutcheon, S J Hassenbusch, E Holland,[...]. J Neurosurg 2001
46

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Roger Stupp, Warren P Mason, Martin J van den Bent, Michael Weller, Barbara Fisher, Martin J B Taphoorn, Karl Belanger, Alba A Brandes, Christine Marosi, Ulrich Bogdahn,[...]. N Engl J Med 2005
41

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.
Walter Stummer, Uwe Pichlmeier, Thomas Meinel, Otmar Dieter Wiestler, Friedhelm Zanella, Hans-Jürgen Reulen. Lancet Oncol 2006
26


The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
23

Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis.
Timothy J Brown, Matthew C Brennan, Michael Li, Ephraim W Church, Nicholas J Brandmeir, Kevin L Rakszawski, Akshal S Patel, Elias B Rizk, Dima Suki, Raymond Sawaya,[...]. JAMA Oncol 2016
398
22

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
Roger Stupp, Monika E Hegi, Warren P Mason, Martin J van den Bent, Martin J B Taphoorn, Robert C Janzer, Samuel K Ludwin, Anouk Allgeier, Barbara Fisher, Karl Belanger,[...]. Lancet Oncol 2009
16

Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.
Annette M Molinaro, Shawn Hervey-Jumper, Ramin A Morshed, Jacob Young, Seunggu J Han, Pranathi Chunduru, Yalan Zhang, Joanna J Phillips, Anny Shai, Marisa Lafontaine,[...]. JAMA Oncol 2020
122
16

Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
Matthew J McGirt, Kaisorn L Chaichana, Muraya Gathinji, Frank J Attenello, Khoi Than, Alessandro Olivi, Jon D Weingart, Henry Brem, Alf Redo Quiñones-Hinojosa. J Neurosurg 2009
484
15

MGMT gene silencing and benefit from temozolomide in glioblastoma.
Monika E Hegi, Annie-Claire Diserens, Thierry Gorlia, Marie-France Hamou, Nicolas de Tribolet, Michael Weller, Johan M Kros, Johannes A Hainfellner, Warren Mason, Luigi Mariani,[...]. N Engl J Med 2005
14

Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.
Kaisorn L Chaichana, Ignacio Jusue-Torres, Rodrigo Navarro-Ramirez, Shaan M Raza, Maria Pascual-Gallego, Aly Ibrahim, Marta Hernandez-Hermann, Luis Gomez, Xiaobu Ye, Jon D Weingart,[...]. Neuro Oncol 2014
269
14

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.
Roger Stupp, Sophie Taillibert, Andrew Kanner, William Read, David Steinberg, Benoit Lhermitte, Steven Toms, Ahmed Idbaih, Manmeet S. Ahluwalia, Karen Fink,[...]. JAMA 2017
792
13

Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.
Olivier L Chinot, Wolfgang Wick, Warren Mason, Roger Henriksson, Frank Saran, Ryo Nishikawa, Antoine F Carpentier, Khe Hoang-Xuan, Petr Kavan, Dana Cernea,[...]. N Engl J Med 2014
13

Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial.
Christian Senft, Andrea Bink, Kea Franz, Hartmut Vatter, Thomas Gasser, Volker Seifert. Lancet Oncol 2011
473
13

Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.
Justin S Smith, Edward F Chang, Kathleen R Lamborn, Susan M Chang, Michael D Prados, Soonmee Cha, Tarik Tihan, Scott Vandenberg, Michael W McDermott, Mitchel S Berger. J Clin Oncol 2008
804
13

Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias.
Walter Stummer, Hanns-Jürgen Reulen, Thomas Meinel, Uwe Pichlmeier, Wiebke Schumacher, Jörg-Christian Tonn, Veit Rohde, Falk Oppel, Bernd Turowski, Christian Woiciechowsky,[...]. Neurosurgery 2008
648
13

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Pieter Wesseling, Daniel J Brat, Ian A Cree, Dominique Figarella-Branger, Cynthia Hawkins, H K Ng, Stefan M Pfister, Guido Reifenberger,[...]. Neuro Oncol 2021
669
13

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.
Patrick Y Wen, David R Macdonald, David A Reardon, Timothy F Cloughesy, A Gregory Sorensen, Evanthia Galanis, John Degroot, Wolfgang Wick, Mark R Gilbert, Andrew B Lassman,[...]. J Clin Oncol 2010
12

Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
Matthew M Grabowski, Pablo F Recinos, Amy S Nowacki, Jason L Schroeder, Lilyana Angelov, Gene H Barnett, Michael A Vogelbaum. J Neurosurg 2014
219
12

A randomized trial of bevacizumab for newly diagnosed glioblastoma.
Mark R Gilbert, James J Dignam, Terri S Armstrong, Jeffrey S Wefel, Deborah T Blumenthal, Michael A Vogelbaum, Howard Colman, Arnab Chakravarti, Stephanie Pugh, Minhee Won,[...]. N Engl J Med 2014
11

Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis.
Philip C De Witt Hamer, Santiago Gil Robles, Aeilko H Zwinderman, Hugues Duffau, Mitchel S Berger. J Clin Oncol 2012
559
11

Glioma extent of resection and its impact on patient outcome.
Nader Sanai, Mitchel S Berger. Neurosurgery 2008
802
10

The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma.
Maryam Rahman, Joseph Abbatematteo, Edward K De Leo, Paul S Kubilis, Sasha Vaziri, Frank Bova, Elias Sayour, Duane Mitchell, Alfredo Quinones-Hinojosa. J Neurosurg 2017
75
13

IDH1 and IDH2 mutations in gliomas.
Hai Yan, D Williams Parsons, Genglin Jin, Roger McLendon, B Ahmed Rasheed, Weishi Yuan, Ivan Kos, Ines Batinic-Haberle, Siân Jones, Gregory J Riggins,[...]. N Engl J Med 2009
9

An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
Mark E Oppenlander, Andrew B Wolf, Laura A Snyder, Robert Bina, Jeffrey R Wilson, Stephen W Coons, Lynn S Ashby, David Brachman, Peter Nakaji, Randall W Porter,[...]. J Neurosurg 2014
149
9

Supra-complete surgery via dual intraoperative visualization approach (DiVA) prolongs patient survival in glioblastoma.
Ilker Y Eyüpoglu, Nirjhar Hore, Andreas Merkel, Rolf Buslei, Michael Buchfelder, Nicolai Savaskan. Oncotarget 2016
49
18

Functional outcome after language mapping for glioma resection.
Nader Sanai, Zaman Mirzadeh, Mitchel S Berger. N Engl J Med 2008
640
8

Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience.
Ricardo Díez Valle, Sonia Tejada Solis, Miguel Angel Idoate Gastearena, Reyes García de Eulate, Pablo Domínguez Echávarri, Javier Aristu Mendiroz. J Neurooncol 2011
148
8

Epidemiologic and molecular prognostic review of glioblastoma.
Jigisha P Thakkar, Therese A Dolecek, Craig Horbinski, Quinn T Ostrom, Donita D Lightner, Jill S Barnholtz-Sloan, John L Villano. Cancer Epidemiol Biomarkers Prev 2014
548
8

Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
Orin Bloch, Seunggu J Han, Soonmee Cha, Matthew Z Sun, Manish K Aghi, Michael W McDermott, Mitchel S Berger, Andrew T Parsa. J Neurosurg 2012
252
8

Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival.
Daniel Orringer, Darryl Lau, Sameer Khatri, Grettel J Zamora-Berridi, Kathy Zhang, Chris Wu, Neeraj Chaudhary, Oren Sagher. J Neurosurg 2012
190
8

Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
Federico Pessina, Pierina Navarria, Luca Cozzi, Anna Maria Ascolese, Matteo Simonelli, Armando Santoro, Elena Clerici, Marco Rossi, Marta Scorsetti, Lorenzo Bello. J Neurooncol 2017
63
12

Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis.
Kathleen R Lamborn, Susan M Chang, Michael D Prados. Neuro Oncol 2004
370
7

An integrated genomic analysis of human glioblastoma multiforme.
D Williams Parsons, Siân Jones, Xiaosong Zhang, Jimmy Cheng-Ho Lin, Rebecca J Leary, Philipp Angenendt, Parminder Mankoo, Hannah Carter, I-Mei Siu, Gary L Gallia,[...]. Science 2008
7


IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection.
Jason Beiko, Dima Suki, Kenneth R Hess, Benjamin D Fox, Vincent Cheung, Matthew Cabral, Nicole Shonka, Mark R Gilbert, Raymond Sawaya, Sujit S Prabhu,[...]. Neuro Oncol 2014
270
7


Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.
Matthew J McGirt, Kaisorn L Chaichana, Frank J Attenello, Jon D Weingart, Khoi Than, Peter C Burger, Alessandro Olivi, Henry Brem, Alfredo Quinoñes-Hinojosa. Neurosurgery 2008
342
7

Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article.
Laurent Capelle, Denys Fontaine, Emmanuel Mandonnet, Luc Taillandier, Jean Louis Golmard, Luc Bauchet, Johan Pallud, Philippe Peruzzi, Marie Hélène Baron, Michèle Kujas,[...]. J Neurosurg 2013
258
7

Lomustine and Bevacizumab in Progressive Glioblastoma.
Wolfgang Wick, Thierry Gorlia, Martin Bendszus, Martin Taphoorn, Felix Sahm, Inga Harting, Alba A Brandes, Walter Taal, Julien Domont, Ahmed Idbaih,[...]. N Engl J Med 2017
374
7

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.
Quinn T Ostrom, Nirav Patil, Gino Cioffi, Kristin Waite, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2020
457
7

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
Jeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, Kyle M Walsh, Paul A Decker, Hugues Sicotte, Melike Pekmezci, Terri Rice, Matt L Kosel, Ivan V Smirnov,[...]. N Engl J Med 2015
6

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.
Quinn T Ostrom, Gino Cioffi, Haley Gittleman, Nirav Patil, Kristin Waite, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2019
894
6

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, Victoria Wang, Yuan Qi, Matthew D Wilkerson, C Ryan Miller, Li Ding, Todd Golub, Jill P Mesirov,[...]. Cancer Cell 2010
6

Maximizing safe resection of low- and high-grade glioma.
Shawn L Hervey-Jumper, Mitchel S Berger. J Neurooncol 2016
189
6

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack, Joachim Peter Steinbach, Uwe Schlegel, Michael Sabel, Peter Hau, Rolf-Dieter Kortmann, Dietmar Krex, Oliver Grauer,[...]. Lancet 2019
200
6

The 2007 WHO classification of tumours of the central nervous system.
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
6

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.
Edward R Laws, Ian F Parney, Wei Huang, Fred Anderson, Angel M Morris, Anthony Asher, Kevin O Lillehei, Mark Bernstein, Henry Brem, Andrew Sloan,[...]. J Neurosurg 2003
470
5


The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis.
Maarten M J Wijnenga, Pim J French, Hendrikus J Dubbink, Winand N M Dinjens, Peggy N Atmodimedjo, Johan M Kros, Marion Smits, Renske Gahrmann, Geert-Jan Rutten, Jeroen B Verheul,[...]. Neuro Oncol 2018
132
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.